Aytu Biopharma, Inc.
AYTU
$2.59
-$0.01-0.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -7.98% | 5.42% | 70.32% | -10.91% | 1.44% |
| Total Receivables | -6.93% | 6.64% | -13.04% | 41.03% | 9.69% |
| Inventory | -14.30% | -11.67% | 3.40% | -0.24% | -5.57% |
| Prepaid Expenses | 28.77% | -8.58% | -24.38% | 20.90% | 7.59% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -6.00% | 2.44% | 9.19% | 15.00% | 3.81% |
|
|
|||||
| Total Current Assets | -6.00% | 2.44% | 9.19% | 15.00% | 3.81% |
| Net Property, Plant & Equipment | -4.44% | -5.21% | -3.86% | -2.18% | -11.63% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 5.18% | -1.83% | -13.36% | -2.50% | -2.44% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -21.41% | -22.01% | -8.86% | -13.21% | -22.78% |
| Total Assets | -2.39% | 0.65% | -0.02% | 6.86% | 0.34% |
|
|
|||||
| Total Accounts Payable | 15.53% | 16.42% | -11.96% | 2.92% | -13.42% |
| Total Accrued Expenses | 2.22% | 6.47% | -13.66% | -10.52% | 0.91% |
| Short-term Debt | -38.98% | 64.11% | -9.62% | 149.95% | -6.04% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.19% | 3.26% | 1.79% | -3.92% | -12.90% |
| Total Finance Division Other Current Liabilities | 15.12% | -21.71% | -9.85% | 9.26% | 23.16% |
| Total Other Current Liabilities | 15.12% | -21.71% | -9.85% | 9.26% | 23.16% |
| Total Current Liabilities | -0.65% | 4.64% | -10.81% | 10.40% | 4.56% |
|
|
|||||
| Total Current Liabilities | -0.65% | 4.64% | -10.81% | 10.40% | 4.56% |
| Long-Term Debt | -4.30% | -4.11% | 14.26% | -4.49% | -4.29% |
| Short-term Debt | -38.98% | 64.11% | -9.62% | 149.95% | -6.04% |
| Capital Leases | -4.89% | 3.86% | -1.60% | -9.49% | -3.32% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 28.38% | -19.54% | 275.47% | -21.93% | -21.66% |
| Total Liabilities | 5.88% | -3.23% | 17.81% | 4.49% | -0.63% |
|
|
|||||
| Common Stock & APIC | 0.45% | 0.64% | 1.11% | 0.04% | 0.04% |
| Retained Earnings | -3.19% | 0.59% | -6.32% | 1.26% | 0.25% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -38.71% | 22.17% | -45.65% | 13.43% | 3.15% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -38.71% | 22.17% | -45.65% | 13.43% | 3.15% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -38.71% | 22.17% | -45.65% | 13.43% | 3.15% |
|
|
|||||